James Wentworth
Corporate Officer/Principal at TRANSGENE
James Wentworth active positions
| Companies | Position | Start | End |
|---|---|---|---|
| TRANSGENE | Corporate Officer/Principal | 21/01/2024 | - |
Career history of James Wentworth
Former positions of James Wentworth
| Companies | Position | Start | End |
|---|---|---|---|
Adaptimmune Ltd.
 Adaptimmune Ltd. Medical/Nursing ServicesHealth Services Adaptimmune Ltd. develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. It utilizes the T cell to target and destroy cancerous and infected cells by using affinity T cell receptor proteins as a means of strengthening patient T cell responses. The company was founded by Bent K. Jakobsen, James Julian Noble and Helena Katrina Tayton-Martin in 2008 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | - | - |
Training of James Wentworth
| University of Bristol | Doctorate Degree |
| International Institute for Management Development | Masters Business Admin |
Statistics
International
| United Kingdom | 3 |
| France | 2 |
| Switzerland | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 2 |
| Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| TRANSGENE | Health Technology |
| Private companies | 1 |
|---|---|
Adaptimmune Ltd.
Adaptimmune Ltd. Medical/Nursing ServicesHealth Services Adaptimmune Ltd. develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. It utilizes the T cell to target and destroy cancerous and infected cells by using affinity T cell receptor proteins as a means of strengthening patient T cell responses. The company was founded by Bent K. Jakobsen, James Julian Noble and Helena Katrina Tayton-Martin in 2008 and is headquartered in Oxford, the United Kingdom. | Health Services |
- Stock Market
- Insiders
- James Wentworth
- Experience
